Skip to main content

. 1960 Apr 9;1(5179):1103–1105. doi: 10.1136/bmj.1.5179.1103

Treatment of Functional Menstrual Disorders with Norethisterone

P M F Bishop, J C Cabral de Almeida

PMCID: PMC1966933 PMID: 13800996

1103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

GREENBLATT R. B. The progestational activity of 17-alpha-ethinyl-19-nortestosterone. J Clin Endocrinol Metab. 1956 Jul;16(7):869–875. doi: 10.1210/jcem-16-7-869. [DOI] [PubMed] [Google Scholar]
HERTZ R., TULLNER W., RAFFELT E. Progestational activity of orally administered 17 alpha-ethinyl-19-nortestosterone. Endocrinology. 1954 Feb;54(2):228–230. doi: 10.1210/endo-54-2-228. [DOI] [PubMed] [Google Scholar]
McGINTY D. A. Some chemical and biological properties of 19-nor-17 alpha-ethynyltestosterone. Ann N Y Acad Sci. 1958 Jul 30;71(5):500–515. doi: 10.1111/j.1749-6632.1958.tb46781.x. [DOI] [PubMed] [Google Scholar]
POTS P. Die perorale Wirksamkeit synthetischer Gestagene. Zentralbl Gynakol. 1957 Apr 6;79(14):529–539. [PubMed] [Google Scholar]

ACTIONS

RESOURCES